Related Experiment Videos
Factors associated with the recommendation for endocarditis prophylaxis in mitral value prolapse
C J Lavie1, B K Khandheria, J B Seward
1Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905.
JAMA
|December 15, 1989
Summary
Physicians recommend endocarditis prophylaxis less often for older patients with mitral valve prolapse. Age and mitral regurgitation significantly influence prophylaxis decisions, highlighting a need for updated guidelines.
Area of Science:
- Cardiology
- Clinical Decision Making
- Epidemiology
Background:
- Mitral valve prolapse (MVP) is a common valvular heart condition.
- Current guidelines for endocarditis prophylaxis in MVP lack specific age and echocardiographic criteria.
- Physician decision-making for prophylaxis in MVP patients requires further investigation.
Purpose of the Study:
- To investigate the association between patient characteristics (age, echocardiography) and physician recommendations for endocarditis prophylaxis in isolated mitral valve prolapse.
- To identify factors influencing clinical decisions regarding prophylaxis in MVP.
Main Methods:
- Population-based study of 127 Olmsted County residents with newly diagnosed isolated MVP.
- Analysis using multiple logistic regression.
- Inclusion of clinical and Doppler echocardiographic data.
Main Results:
- Endocarditis prophylaxis recommendations were 3-4 times more frequent in patients <40 years vs >60 years.
- A 10-year increase in age was independently associated with a 30% reduction in prophylaxis recommendations.
- Doppler-detected mitral regurgitation independently predicted prophylaxis recommendations.
- Physical exam findings (murmur, click) showed weak associations; mitral valve thickening showed no association.
Conclusions:
- Age and Doppler-identified mitral regurgitation are strongly associated with prophylaxis recommendations for MVP, despite not being current guideline factors.
- Clinical practice deviates from guidelines, suggesting a need for evidence-based updates.
- Further longitudinal studies are required to refine endocarditis risk stratification in MVP subgroups.